Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in ...

Novel combination with neoadjuvant eftilagimod alfa (efti) achieves significant 51.5% tumour hyalinization/fibrosis across multiple soft tissue ...

Not for distribution to U.S. newswire services or dissemination in the United States.TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Flagship ...

Gallant is developing FDA-regulated, off-the-shelf mesenchymal stromal cell therapies to rapidly modulate inflammation, support tissue repair, and make stem cell treatment broadly available to cats ...

Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient ...

The UK's Strategic Defence Review (SDR) 2025, published in June, put significant emphasis on the greater employment and ...

The national men’s and women’s indoor hockey squads departed for Prague, Czech Republic, yesterday to participate in a series ...

Alzheimer's disease (AD), the leading cause of dementia, affects nearly 40 million individuals globally, resulting in a ...

Replacing APOE4 with APOE2 in adult mice rapidly reshapes brain lipids and gene expression, even after development is ...

As new ownership looks to overhaul a mobile home park, the majority of residents have formed a union in the hopes of pushing ...

Our High Voltage column wraps all the news driving ASX stocks with exposure to lithium, cobalt, graphite, nickel, rare earths ...